Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

BackgroundFew data are available about the durability of the response, the induction of neutralizing antibodies, and the cellular response upon the third dose of the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in hemato-oncological patients.ObjectiveTo investigate the a...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Valentina Laquintana, Carla Mottini, Francesco Marchesi, Benedetta Marcozzi, Irene Terrenato, Eleonora Sperandio, Luisa de Latouliere, Francesca Carrieri, Fulvia Pimpinelli, Martina Pontone, Raul Pellini, Flaminia Campo, Laura Conti, Celeste Accetta, Chiara Mandoj, Fabrizio Petrone, Ornella Di Bella, Branka Vujovic, Aldo Morrone, Mirco Compagnone, Eugenia Principato, Eleonora Pinto, Elena Papa, Paolo Falcucci, Antonia La Malfa, Matteo Pallocca, Federico De Marco, Giulia Piaggio, Gennaro Ciliberto, Andrea Mengarelli, Simona di Martino
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2024-01-01
Cyfres:	Frontiers in Immunology
Pynciau:	COVID-19 SARS-CoV-2 mRNA vaccine humoral and cellular response hematological patients
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1221587/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!